Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Explore how Sp 500 stacks up against the Total Stock Market for retirement investing, focusing on long-term growth, volatility, and portfolio diversification.
28,492 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
Intel stunned investors with a triple-digit rally in early 2026. This guide breaks down why intel stock soared 278%, ...
A controversial post and a geopolitical rumor collide with everyday money concerns. This article shows how to transla...
DexCom and Insulet sit at the heart of diabetes technology. This in-depth look examines growth drivers, financials, a...
As the energy transition unfolds, two giants stand out: Chevron and Exxon Mobil. This guide breaks down which stock m...
President Trump weighs a roughly 30-day postponement of his summit with Xi as Iran escalates. The decision could shif...
A surge in market volatility and weaker-than-expected data have sparked a debate: has the deep recession already star...
XRP shows a modest rebound but remains below critical resistance, signaling caution rather than a breakout. The marke...
A Goldman Sachs trading desk note argues that heavy institutional deleveraging has run its course, suggesting a poten...
Oil markets moved higher for the week as geopolitical risk and supply worries outweighed new data. u.s. prices turn h...
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
The Procure Space ETF has delivered a standout 12-month return as investors chase growth in space-enabled industries....